Literature DB >> 21856339

Post-translational modifications of Hsp90 and their contributions to chaperone regulation.

Mehdi Mollapour1, Len Neckers.   

Abstract

Molecular chaperones, as the name suggests, are involved in folding, maintenance, intracellular transport, and degradation of proteins as well as in facilitating cell signaling. Heat shock protein 90 (Hsp90) is an essential eukaryotic molecular chaperone that carries out these processes in normal and cancer cells. Hsp90 function in vivo is coupled to its ability to hydrolyze ATP and this can be regulated by co-chaperones and post-translational modifications. In this review, we explore the varied roles of known post-translational modifications of cytosolic and nuclear Hsp90 (phosphorylation, acetylation, S-nitrosylation, oxidation and ubiquitination) in fine-tuning chaperone function in eukaryotes. This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90). Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856339      PMCID: PMC3226900          DOI: 10.1016/j.bbamcr.2011.07.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  138 in total

1.  What is a co-chaperone?

Authors:  Avrom J Caplan
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

Review 2.  Structure and mechanism of the Hsp90 molecular chaperone machinery.

Authors:  Laurence H Pearl; Chrisostomos Prodromou
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Large-scale phosphorylation analysis of mouse liver.

Authors:  Judit Villén; Sean A Beausoleil; Scott A Gerber; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

4.  Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes.

Authors:  Hetian Lei; Annapurna Venkatakrishnan; Soyoung Yu; Andrius Kazlauskas
Journal:  J Biol Chem       Date:  2007-01-03       Impact factor: 5.157

5.  Substrate binding drives large-scale conformational changes in the Hsp90 molecular chaperone.

Authors:  Timothy O Street; Laura A Lavery; David A Agard
Journal:  Mol Cell       Date:  2011-04-08       Impact factor: 17.970

Review 6.  Using natural product inhibitors to validate Hsp90 as a molecular target in cancer.

Authors:  Len Neckers
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

7.  Post-translational modification of heat-shock protein 90: impact on chaperone function.

Authors:  Bradley T Scroggins; Len Neckers
Journal:  Expert Opin Drug Discov       Date:  2007-10       Impact factor: 6.098

8.  Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

Authors:  Klarisa Rikova; Ailan Guo; Qingfu Zeng; Anthony Possemato; Jian Yu; Herbert Haack; Julie Nardone; Kimberly Lee; Cynthia Reeves; Yu Li; Yerong Hu; Zhiping Tan; Matthew Stokes; Laura Sullivan; Jeffrey Mitchell; Randy Wetzel; Joan Macneill; Jian Min Ren; Jin Yuan; Corey E Bakalarski; Judit Villen; Jon M Kornhauser; Bradley Smith; Daiqiang Li; Xinmin Zhou; Steven P Gygi; Ting-Lei Gu; Roberto D Polakiewicz; John Rush; Michael J Comb
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

Review 9.  The morphogenesis checkpoint: how yeast cells watch their figures.

Authors:  Daniel J Lew
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

10.  Structural and functional coupling of Hsp90- and Sgt1-centred multi-protein complexes.

Authors:  Minghao Zhang; Marta Botër; Kuoyu Li; Yasuhiro Kadota; Barry Panaretou; Chrisostomos Prodromou; Ken Shirasu; Laurence H Pearl
Journal:  EMBO J       Date:  2008-09-25       Impact factor: 11.598

View more
  124 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

2.  Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.

Authors:  Wanping Xu; Mehdi Mollapour; Chrisostomos Prodromou; Suiquan Wang; Bradley T Scroggins; Zach Palchick; Kristin Beebe; Marco Siderius; Min-Jung Lee; Anthony Couvillon; Jane B Trepel; Yoshihiko Miyata; Robert Matts; Len Neckers
Journal:  Mol Cell       Date:  2012-06-21       Impact factor: 17.970

Review 3.  Hsp90 in Cancer: Transcriptional Roles in the Nucleus.

Authors:  Stuart K Calderwood; Len Neckers
Journal:  Adv Cancer Res       Date:  2015-10-12       Impact factor: 6.242

Review 4.  Chaperome heterogeneity and its implications for cancer study and treatment.

Authors:  Tai Wang; Anna Rodina; Mark P Dunphy; Adriana Corben; Shanu Modi; Monica L Guzman; Daniel T Gewirth; Gabriela Chiosis
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

Review 5.  Adapting to stress - chaperome networks in cancer.

Authors:  Suhasini Joshi; Tai Wang; Thaís L S Araujo; Sahil Sharma; Jeffrey L Brodsky; Gabriela Chiosis
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

Review 6.  Unconventional Approaches to Modulating the Immunogenicity of Tumor Cells.

Authors:  Laurence Booth; Jane L Roberts; John Kirkwood; Andrew Poklepovic; Paul Dent
Journal:  Adv Cancer Res       Date:  2018-01-03       Impact factor: 6.242

Review 7.  Toxoplasma gondii Hsp90: potential roles in essential cellular processes of the parasite.

Authors:  Sergio O Angel; Maria J Figueras; Maria L Alomar; Pablo C Echeverria; Bin Deng
Journal:  Parasitology       Date:  2014-02-21       Impact factor: 3.234

8.  Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor.

Authors:  Klaus-Dieter Preuss; Michael Pfreundschuh; Martin Weigert; Natalie Fadle; Evi Regitz; Boris Kubuschok
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

9.  LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung.

Authors:  Nektarios Barabutis; Vaishali Handa; Christiana Dimitropoulou; Ruslan Rafikov; Connie Snead; Sanjiv Kumar; Atul Joshi; Gagan Thangjam; David Fulton; Stephen M Black; Vijay Patel; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-12       Impact factor: 5.464

10.  Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.

Authors:  Mehdi Mollapour; Dimitra Bourboulia; Kristin Beebe; Mark R Woodford; Sigrun Polier; Anthony Hoang; Raju Chelluri; Yu Li; Ailan Guo; Min-Jung Lee; Elham Fotooh-Abadi; Sahar Khan; Thomas Prince; Naoto Miyajima; Soichiro Yoshida; Shinji Tsutsumi; Wanping Xu; Barry Panaretou; William G Stetler-Stevenson; Gennady Bratslavsky; Jane B Trepel; Chrisostomos Prodromou; Len Neckers
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.